Jian Zhao (J Zhao)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Inferior Vena Cava

Anti Inflammatory Drugs

Cardiovascular Events

Top Venues

Alimentary pharmacology & therapeutics

The Journal of international medical research

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiamei Wang, Feng Wen, Jian Zhao
Letter: Risks of proton pump inhibitor treatment in cirrhotic patients. Alimentary pharmacology & therapeutics 59 (12) (2024)
Jiamei Wang, Feng Wen, Jian Zhao
Letter: Risks of proton pump inhibitor treatment in cirrhotic patients. Alimentary pharmacology & therapeutics (2024)
Jiamei Wang, Feng Wen, Jian Zhao
Letter: Risks of proton pump inhibitor treatment in cirrhotic patients. Alimentary pharmacology & therapeutics 59 (12) (2024)
Jian Zhao, Kun Huang, Bowen Hu
Letter: factors influencing discontinuation of aspirin in patients after gastrointestinal bleeding. Alimentary pharmacology & therapeutics 57 (11) (2023)
Jian Zhao, Kun Huang, Bowen Hu
Letter: factors influencing discontinuation of aspirin in patients after gastrointestinal bleeding. Alimentary pharmacology & therapeutics 57 (11) (2023)
Jian Zhao
Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 58 (9) (2023)
Xueyang Zheng, Na Li, Jian Zhao
Letter: proton pump inhibitors and risk of myocardial infarction. Alimentary pharmacology & therapeutics 55 (1) (2022)
Bowen Hu, Jian Zhao, Xin Liang, Changzhen Ren, Na Li, Chun Liang
A case of complete atrioventricular block associated with primary cardiac lymphoma reversed without cardiac pacemaker implantation. The Journal of international medical research 50 (4) (2022)
Jian Zhao, Jing Yang, Wei Chen, Xiaomin Yang, Yaoting Liu, Xiaoliang Cong, Zhigang Huang, Na Li
Acute myocardial infarction as the first sign of infective endocarditis: a case report. The Journal of international medical research 48 (12) (2021)
Bo Wei, Junxue Wang, Yanda Zhang, Jian Zhao
Letter: inflammatory bowel disease and risk of myocardial infarction. Alimentary pharmacology & therapeutics 51 (6) (2020)
Jian Zhao
Letter: the risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel. Alimentary pharmacology & therapeutics 52 (7) (2020)
Jian Zhao, Lingling Fang, Yawen Song, Chun Liang
Letter: the association between chronic viral hepatitis and metabolic syndrome. Alimentary pharmacology & therapeutics 49 (2) (2019)
Jian Zhao, J M Wang, X W Zhang, R An, Chun Liang
Letter: proton pump inhibitor use and risk of fracture. Alimentary pharmacology & therapeutics 47 (11) (2019)
Jian Zhao, Y Zhang, H Tian, H Sun, Chun Liang
Letter: the efficacy and safety of rifaximin for the prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients. Alimentary pharmacology & therapeutics 47 (5) (2019)
Jian Zhao, Li Hua, Na Li, Ran An, Chun Liang
Letter: proton pump inhibitors use and risk of hepatocellular carcinoma: A meta-analysis of observational studies. Alimentary pharmacology & therapeutics 48 (8) (2019)
Jian Zhao, X Zhang, H Sun, R An
Is psoriasis a risk factor of angiography-proven coronary artery disease? The British journal of dermatology 179 (5) (2018)
Jian Zhao, H Tian, C Liang
Letter: the treatment of coronary artery disease in cirrhotics needs more thinking. Alimentary pharmacology & therapeutics 46 (6) (2017)
Jian Zhao, H Tian, C Liang
Letter: safety and efficacy of using statins in patients with cirrhosis. Alimentary pharmacology & therapeutics 46 (11-12) (2017)